{
  "id": "cluster_7_doc4",
  "content": "Editorial in The Spine Journal highlights reimbursement challenges for osteobiologic agents in elderly spinal surgery patients. Oakridge Hospital case studied demonstrates 37-day average delay in medication approval through SilverCross-backed plans compared to 12-day average for other networks.",
  "metadata": {
    "format": "news_article"
  }
}